Zoetis Beheer

Beheer criteriumcontroles 4/4

De CEO Zoetis is Kristin Peck, benoemd in Jan2020, heeft een ambtstermijn van 4.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 15.24M, bestaande uit 7.9% salaris en 92.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.018% van de aandelen van het bedrijf, ter waarde $ 14.19M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 11 jaar.

Belangrijke informatie

Kristin Peck

Algemeen directeur

US$15.2m

Totale compensatie

Percentage CEO-salaris7.9%
Dienstverband CEO4.8yrs
Eigendom CEO0.02%
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuur11yrs

Recente managementupdates

Recent updates

Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy

Nov 18

Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet

Oct 26
Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet

Zoetis: A Solid Choice For The Young Dividend Growth Investor

Oct 09

Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Oct 08
Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Zoetis: Investing In Pet Health And Portfolio Wealth

Sep 26

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

Sep 20
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Aug 30
There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Aug 13

Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)

Aug 07

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Jul 16
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price

Jul 03

Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader

Jun 11

A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Jun 10
A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

May 23
Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

Zoetis: Why The Focus On Companion Animal Segment Will Pay Off

May 22

The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 04
The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Zoetis: Long-Term Buy Despite Safety Concerns

May 03

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Apr 12
Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Zoetis: My Favorite Healthcare Stock Right Now

Mar 21

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Mar 03
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness

Feb 27

Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns

Jan 10

Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Jan 01
Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Dec 06
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Nov 18
Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Zoetis: High-Quality Compounder With A Reasonable Price After Earnings

Nov 09

Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now

Oct 26

Zoetis Is An Impressive Healthcare Compounder

Sep 26

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.

Aug 22

Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Aug 12
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Zoetis: My Dog Approves Of This Dividend Compounder

Jul 19

Zoetis: A Purrfect Addition To Your Portfolio

Jun 22

Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

Jun 10
Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Mar 10
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus

Feb 14

Analyse CEO-vergoeding

Hoe is Kristin Peck's beloning veranderd ten opzichte van Zoetis's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

US$2b

Jun 30 2024n/an/a

US$2b

Mar 31 2024n/an/a

US$2b

Dec 31 2023US$15mUS$1m

US$2b

Sep 30 2023n/an/a

US$2b

Jun 30 2023n/an/a

US$2b

Mar 31 2023n/an/a

US$2b

Dec 31 2022US$14mUS$1m

US$2b

Sep 30 2022n/an/a

US$2b

Jun 30 2022n/an/a

US$2b

Mar 31 2022n/an/a

US$2b

Dec 31 2021US$13mUS$1m

US$2b

Sep 30 2021n/an/a

US$2b

Jun 30 2021n/an/a

US$2b

Mar 31 2021n/an/a

US$2b

Dec 31 2020US$10mUS$1m

US$2b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$2b

Mar 31 2020n/an/a

US$2b

Dec 31 2019US$3mUS$690k

US$2b

Sep 30 2019n/an/a

US$1b

Jun 30 2019n/an/a

US$1b

Mar 31 2019n/an/a

US$1b

Dec 31 2018US$3mUS$675k

US$1b

Sep 30 2018n/an/a

US$1b

Jun 30 2018n/an/a

US$1b

Mar 31 2018n/an/a

US$978m

Dec 31 2017US$3mUS$655k

US$864m

Compensatie versus markt: De totale vergoeding ($USD 15.24M ) Kristin } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.66M ).

Compensatie versus inkomsten: De vergoeding van Kristin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Kristin Peck (53 yo)

4.8yrs

Tenure

US$15,237,853

Compensatie

Ms. Kristin C. Peck serves as an Independent Director at BlackRock, Inc. since joining on September 29, 2021. She has been the Chief Executive Officer of Zoetis Inc. since January 01, 2020 and its Director...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Kristin Peck
CEO & Director4.8yrsUS$15.24m0.018%
$ 14.2m
Wetteny Joseph
Executive VP & CFO3.4yrsUS$4.25m0.0034%
$ 2.7m
Wafaa Mamilli
EVP & Group President for Chinano dataUS$2.69m0.0015%
$ 1.2m
Robert Polzer
Executive VP and President of Research & Development9.8yrsUS$2.44m0.00095%
$ 758.5k
Keith Sarbaugh
Executive VP & Chief Digital and Technology Officerno datageen gegevens0.00022%
$ 175.6k
Steven Frank
Vice President of Investor Relationsno datageen gegevensgeen gegevens
Roxanne Lagano
Executive VPless than a yeargeen gegevens0.0035%
$ 2.8m
William Price
VP & Chief Communications Officerno datageen gegevensgeen gegevens
Julie Fuller
Executive VPless than a yeargeen gegevens0.000020%
$ 16.0k
Jeannette Astorga
Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer4.2yrsgeen gegevens0.00015%
$ 119.8k
Nick Ashton
Executive VP and President of Global Manufacturing & Supply2.5yrsgeen gegevens0.00014%
$ 111.8k
Jamie Brannan
Chief Commercial Officerno datageen gegevens0.00043%
$ 343.3k

2.5yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van ZTS wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kristin Peck
CEO & Director5.1yrsUS$15.24m0.018%
$ 14.2m
Louise Parent
Independent Director11.3yrsUS$370.00k0.0030%
$ 2.4m
Michael McCallister
Independent Non-Executive Chairman11.8yrsUS$490.00k0.0057%
$ 4.6m
Paul Bisaro
Independent Director9.5yrsUS$340.00k0.0048%
$ 3.9m
Frank D'Amelio
Independent Director12.3yrsUS$340.50k0.0033%
$ 2.6m
Sanjay Khosla
Independent Director11.4yrsUS$340.00k0.0022%
$ 1.7m
Robert Scully
Independent Director11.4yrsUS$365.00k0.0044%
$ 3.5m
Gavin D. Hattersley
Independent Directorless than a yeargeen gegevens0.00017%
$ 135.7k
Gregory Norden
Independent Director11.8yrsUS$365.00k0.0034%
$ 2.7m
Willie Reed
Independent Director10.7yrsUS$370.00k0.0022%
$ 1.8m
Vanessa Broadhurst
Independent Director2.3yrsUS$341.00k0.00023%
$ 183.6k
Antoinette Leatherberry
Independent Director3.9yrsUS$340.00k0.00049%
$ 391.2k

11.0yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ZTS zijn ervaren en ervaren (gemiddelde ambtstermijn van 11 jaar).